Aufrufe: 14
If you purchased or otherwise acquired ASP Isotopes Inc. (NASDAQ: ASPI) securities prior to September 26, 2024 and still hold shares today, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever. Please visit https://grabarlaw.com/the-latest/aspi-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085.
Why? On December 4, 2025, the United States District Court for the Southern District of New York denied in part defendants' motion to dismiss and underlying securities fraud class action complaint against ASP Isotopes (NASADQ: ASPI) and certain of its officers, allowing key securities fraud claims to move forward.
According to that complaint, beginning in September 2024, the Company and its executives made statements to investors regarding ASP Isotopes' ability to enrich uranium using proprietary technology. The lawsuit alleges that these statements were materially false and misleading because the Company had never tested its purported uranium enrichment technologies on uranium, whether at laboratory, pilot, or commercial scale.
The complaint further alleges that defendants used these misrepresentations to raise capital from investors, generating approximately $18.6 million in gross proceeds while the Company's stock price was allegedly inflated by misleading statements about its uranium enrichment capabilities.
What Can You Do Now? If you purchased or otherwise acquired ASP Isotopes Inc. (NASDAQ: ASPI) securities prior to September 26, 2024 and still hold shares today, please visit https://grabarlaw.com/the-latest/aspi-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever.
#ASPI #ASPIsotopes $ASPI
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290051
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
